Cargando…

AT2 receptor interacting protein 1 (ATIP1) mediates COX-2 induction by an AT2 receptor agonist in endothelial cells

Angiotensin II (Ang II) type 2 receptor (AT2R) is one of the major components of the renin-angiotensin-aldosterone system. Nevertheless, the physiological role is not well defined compared to the understanding of the Ang II type 1 receptor (AT1R), which is a well characterized G-protein coupled rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soda, Keita, Nakada, Yoshiko, Iwanari, Hiroko, Hamakubo, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767795/ https://www.ncbi.nlm.nih.gov/pubmed/33381664 http://dx.doi.org/10.1016/j.bbrep.2020.100850

Ejemplares similares

AT2 Receptor-Interacting Proteins ATIPs in the Brain
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2013)

The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer
por: Louis, Simon N.S., et al.
Publicado: (2011)

G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
por: Hino, Tomoya, et al.
Publicado: (2012)

Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D(2)
por: Nagata, Nanae, et al.
Publicado: (2017)

Atipical kawasaki disease with coronary aneurysm in infant
por: Dodi, Icilio, et al.
Publicado: (2011)

A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
por: Sakihama, Toshiko, et al.
Publicado: (2008)

ATIPS: Automatic Travel Itinerary Planning System for Domestic Areas
por: Chang, Hsien-Tsung, et al.
Publicado: (2016)

Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3
por: Velot, Lauriane, et al.
Publicado: (2015)

Single-Dose Cisplatin Pre-Treatment Enhances Efficacy of ROBO1-Targeted Radioimmunotherapy
por: Fujiwara, Kentaro, et al.
Publicado: (2020)

Generation of biparatopic antibody through two-step targeting of fragment antibodies on antigen using SpyTag and SpyCatcher
por: Akiba, Hiroki, et al.
Publicado: (2020)

The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair
por: Ranjan, Nikhil, et al.
Publicado: (2021)

Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation
por: Chowdhury, A. M. Masudul Azad, et al.
Publicado: (2017)

Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer
por: Haykal, Maria M., et al.
Publicado: (2021)

A Thromboxane A(2) Receptor-Driven COX-2–Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis
por: Eckenstaler, Robert, et al.
Publicado: (2022)

The Expanding Role of the COX Inhibitor/Opioid Receptor Agonist Combination in the Management of Pain
por: Varrassi, Giustino, et al.
Publicado: (2020)

Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
por: Malo, Marcus, et al.
Publicado: (2012)

c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells
por: Hsieh, Hsi-Lung, et al.
Publicado: (2012)

MicroRNA-153 Regulates the Acquisition of Gliogenic Competence by Neural Stem Cells
por: Tsuyama, Jun, et al.
Publicado: (2015)

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study
por: Rogler, Anja, et al.
Publicado: (2014)

High Expression of IL-1RI and EP(2) Receptors in the IL-1β/COX-2 Pathway, and a New Alternative to Non-Steroidal Drugs—Osthole in Inhibition COX-2
por: Kordulewska, Natalia Karolina, et al.
Publicado: (2019)

Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats
por: Jiang, Shuying, et al.
Publicado: (2003)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8
por: Kukulski, F., et al.
Publicado: (2005)

Molecular characterization and phylogenetics of Fennoscandian cowpox virus isolates based on the p4c and atip genes
por: Okeke, Malachy Ifeanyi, et al.
Publicado: (2014)

MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma
por: Zhao, Tingting, et al.
Publicado: (2015)

EGF receptor and COX-1/COX-2 enzyme proteins as related to corresponding mRNAs in human per-operative biopsies of colorectal cancer
por: Asting, Annika Gustafsson, et al.
Publicado: (2013)

The P2Y(2) Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells
por: Liao, Zhongji, et al.
Publicado: (2014)

COX-2 but Not mPGES-1 Contributes to Renal PGE2 Induction and Diabetic Proteinuria in Mice with Type-1 Diabetes
por: Jia, Zhanjun, et al.
Publicado: (2014)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
por: Kim, Sung Dae, et al.
Publicado: (2017)

Anti-fibrotic Potential of AT(2) Receptor Agonists
por: Wang, Yan, et al.
Publicado: (2017)

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
por: del Olmo-Garcia, María Isabel, et al.
Publicado: (2018)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
por: Nauck, Michael A., et al.
Publicado: (2020)

A (90)Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy
por: Fujiwara, Kentaro, et al.
Publicado: (2014)

Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2018)

Regulated Expression of PTPRJ by COX-2/PGE(2) Axis in Endothelial Cells
por: Xu, Xiaobing, et al.
Publicado: (2014)

Antipyretic activity of Caesalpinia digyna (Rottl.) leaves extract along with phytoconstituent’s binding affinity to COX-1, COX-2, and mPGES-1 receptors: In vivo and in silico approaches
por: Emon, Nazim Uddin, et al.
Publicado: (2021)

Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population
por: Zhao, Lei, et al.
Publicado: (2019)

Sigma-1 Receptor Agonists Directly Inhibit Na(V)1.2/1.4 Channels
por: Gao, Xiao-Fei, et al.
Publicado: (2012)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_icvcfev68rn56qt73nm6sshe49